Polygenic embryo screening: four clinical considerations warrant further attention

S Pereira¹, S Carmi², G Altarescu³, J Austin⁴, D Barlevy¹, A Hershlag^{5

6}, E Juengst⁷, K Kostick-Quenet¹, E Kovanci⁸, R B Lathi⁹, M Mukherjee^{1

10}, I Van den Veyver^{11

12}, O Zuk¹³, G Lázaro-Muñoz^{14

15}, T Lencz^{16

17

18}

Affiliations

¹ Center for Medical Ethics and Health Policy, Baylor College of Medicine, One Baylor Plaza, MS420, Houston, TX 77030, USA.
² Braun School of Public Health and Community Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
³ Preimplantation Genetic Unit and lysosomal Clinic, Medical Genetics Institute, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel.
⁴ Departments of Psychiatry and Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
⁵ Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA.
⁶ Zucker School of Medicine, Hofstra University, Hempstead, NY, USA.
⁷ Center for Bioethics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁸ Houston Assisted Reproductive Technologies (HART) Fertility Clinic, The Woodlands, TX, USA.
⁹ Stanford University, Stanford, CA, USA.
¹⁰ Department of Sociology, University of Califorinia, Berkeley, Berkeley, CA 94720 USA.
¹¹ Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, 77030, USA.
¹² Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
¹³ Department of Statistics and Data Science, The Hebrew University of Jerusalem, Jerusalem, Israel.
¹⁴ Center for Bioethics, Harvard Medical School, Boston, MA, USA.
¹⁵ Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
¹⁶ Departments of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
¹⁷ Institute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY, USA.
¹⁸ Division of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, NY, USA.

PMID: 35604365
PMCID: PMC9247413
DOI: 10.1093/humrep/deac110

Polygenic embryo screening: four clinical considerations warrant further attention

S Pereira et al. Hum Reprod. 2022.

. 2022 Jun 30;37(7):1375-1378.

doi: 10.1093/humrep/deac110.

Authors

Affiliations

¹ Center for Medical Ethics and Health Policy, Baylor College of Medicine, One Baylor Plaza, MS420, Houston, TX 77030, USA.
² Braun School of Public Health and Community Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
³ Preimplantation Genetic Unit and lysosomal Clinic, Medical Genetics Institute, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel.
⁴ Departments of Psychiatry and Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
⁵ Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA.
⁶ Zucker School of Medicine, Hofstra University, Hempstead, NY, USA.
⁷ Center for Bioethics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁸ Houston Assisted Reproductive Technologies (HART) Fertility Clinic, The Woodlands, TX, USA.
⁹ Stanford University, Stanford, CA, USA.
¹⁰ Department of Sociology, University of Califorinia, Berkeley, Berkeley, CA 94720 USA.
¹¹ Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, 77030, USA.
¹² Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
¹³ Department of Statistics and Data Science, The Hebrew University of Jerusalem, Jerusalem, Israel.
¹⁴ Center for Bioethics, Harvard Medical School, Boston, MA, USA.
¹⁵ Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
¹⁶ Departments of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
¹⁷ Institute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY, USA.
¹⁸ Division of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, NY, USA.

PMID: 35604365
PMCID: PMC9247413
DOI: 10.1093/humrep/deac110

Abstract

Recent advances in developing polygenic scores have made it possible to screen embryos for common, complex conditions and traits. Polygenic embryo screening (PES) is currently offered commercially, and though there has been much recent media and academic coverage, reproductive specialists' points of view have not yet been prominent in these discussions. We convened a roundtable of multidisciplinary experts, including reproductive specialists to discuss PES and its implications. In this Opinion, we describe four clinically relevant issues associated with the use of PES that have not yet been discussed in the literature and warrant consideration.

Keywords: PRS; embryo screening; genetic screening; genomic risk scores; polygenic embryo screening; polygenic risk scores; trait screening.

© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

PubMed Disclaimer

References

1. Austin JC. Re-conceptualizing risk in genetic counseling: implications for clinical practice. J Genet Counsel 2010;19:228–234. - PMC - PubMed
1. Davis KW. A new kind of embryo genetics screening makes big promises on little evidence. Slate 2021. https://slate.com/technology/2021/07/prs-model-snp-genetic-screening-cou... (21 August 2021, date last accessed).
1. European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHREWyns C, Bergh C, Calhaz-Jorge C, De Geyter C, Kupka MS, Motrenko T, Rugescu I, Smeenk J, Tandler-Schneider A. et al.ART in Europe, 2016: results generated from European registries by ESHRE. Hum Reprod Open 2020;3:hoaa032. - PMC - PubMed
1. Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz LM, Woloshin S.. Helping doctors and patients make sense of health statistics. Psychol Sci Public Interest 2007;8:53–96. - PubMed
1. Grove J, Ripke S, Als TD, Mattheisen M, Walters RK, Won H, Pallesen J, Agerbo E, Andreassen OA, Anney R. et al.; Autism Spectrum Disorder Working Group of the Psychiatric Genomics Consortium. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet 2019;51:431–444. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

R01 HG011711/HG/NHGRI NIH HHS/United States

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Polygenic embryo screening: four clinical considerations warrant further attention

Affiliations

Polygenic embryo screening: four clinical considerations warrant further attention

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources